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Chapter 1. General introduction 
In this chapter, it was described the background from previous studies and the 
purpose of this study. 
1-1. Exercise-induced muscle damage 
Unaccustomed and strenuous exercise causes muscle damage that clinically 
presents as muscular pain and involves protein degradation and ultrastructural changes. 
Muscle damage usually manifests with a delay after exercise and peaks after 
approximately 24-48 h, a condition known as delayed-onset muscle damage. Muscle 
functions, such as energy metabolism and power output, are difficult to maintain in 
damaged muscles. Depending on the magnitude of muscle damage, muscle force at 
isometric and dynamic testing conditions is impaired after exercise [1-4]. Soluble muscle 
enzymes, such as creatine kinase {CK}, are released, indicating a disruption of the 
sarcomere architecture [1, 5] and surface membrane damage [6, 7]. Muscle-damaging 
exercise results in phagocytic infiltration into the damaged muscle, causing an 
inflammatory response that induces delayed-onset muscle damage [8]. Other important 
symptoms of muscle damage are stiffness and swelling of the muscle [9-11]. 
Furthermore, in a previous study [12], central arterial stiffness transiently increased in a 
damaged muscle after exercise, which may have acute unfavorable cardiovascular 
effects. 
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Previous studies have shown that delayed-onset muscle damage is primarily 
induced by mechanical stress, particularly eccentric muscle contractions [13-16]. 
Concentric exercise shortens contracting muscles; by contrast, eccentric exercise forcibly 
lengthens a contracting muscle. During stepping down a slope, the contracting 
quadriceps muscle controls the rate of knee flexion against the force of gravity. In this 
process, the muscle undergoes eccentric contraction with each step. In fact, compared 
to uphill running (i.e., concentric exercise), downhill running (i.e., eccentric contraction) 
causes greater muscle damage [17], moreover, in our unpublished study, which even 
occurs during the low-intensity physical activity of walking. The disturbance of calcium 
homeostasis also causes muscle damage by protease activation [18]. A muscle 
contraction requires a transient increase in intracellular calcium, which is released from 
the sarcoplasmic reticulum into the cytosol through the excitation-contraction coupling 
system. An overload of intracellular calcium activates calpain (a calcium-dependent 
protease), which destroys muscle protein [19]. In addition, phagocyte infiltration into 
muscles occurs after strenuous exercise [8, 20], and an inflammatory response appears 
to be strongly involved in delayed-onset muscle damage. 
Several reports [21-23] about the mechanism of inflammation have demonstrated 
that oxidative stress directly causes damage via oxidation of cell components such as 
lipids, proteins, and deoxyribonucleic acid (DNA) and also acts as a regulator of 
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inflammation. Namely, oxidative stress promotes the translocation of certain redox-
sensitive transcription factors that regulate inflammatory mediators, such as cytokines, 
chemokines, and adhesion molecules, to the nucleus. In response, phagocytes infiltrate 
the tissues expressing these mediators, causing proteolysis, ultrastructural damage, and 
oxidative injury. Prolonged exercise results in reactive oxygen species (ROS) generation 
by the mitochondrial electron transport chain in muscle cells through an increase in 
oxygen consumption [24, 25]. Also, xanthine oxidase is activated via the ischemia-
reperfusion process during exercise, resulting in ROS generation by the capillary 
endothelium in contracting muscles [26, 27]. Therefore, oxidative stress due to exercise 
is involved in delayed-onset muscle damage associated with phagocyte infiltration, 
which is secondary to the increased expression of inflammatory mediators. 
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1-2. Impaired insulin sensitivity after muscle-damaging exercise 
Previous reports showed that downhill running impairs the insulin-stimulated 
activity of i nsu lin receptor substrate-1 (I RS-1), phosphoi nos it ide 3-ki nase (PI3-K), and Akt 
in damaged muscle tissues from healthy humans [26] and animals [27]. In addition, 
glucose transporter 4 (GLUT4) protein level was decreased in damaged muscles 1 and 2 
days after either downhill running [27] or eccentric resistant exercise [28]. It is well 
known that pro-inflammatory cytokines impair glucose transport by inhibiting insulin 
signal transduction in skeletal muscles. A representative cytokine, tumor necrosis factor-
a (TN F-a), prevents insulin-induced activation of the insulin receptor, PI3-K, and Akt in 
muscle tissue [29-31]. In contrast, inhibition of TNF-a induced signaling prevents this 
impairment of insulin-mediated Akt phosphorylation and glucose uptake [32]. In 
exercise-induced muscle damage, endotoxin-induced production of TNF-a by 
mononuclear cells is increased and positively correlates with reduced insulin-stimulated 
activity of PI3-K [26], which presumably decreases insulin-mediated glucose uptake in 
skeletal muscles. Other studies also reported that at 24-48 h after muscle-damaging 
exercise in humans and animals, levels of interleukin (IL)-1~, IL-6, monocyte 
chemoattractant protein-1, and IL-8 are increased in muscle tissues [33-35]. These 
inflammatory factors may be partly associated with the initiation and progression of 
impaired muscle damage-induced insulin signaling. 
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Elevated generation of ROS in delayed-onset muscle damage can also impair 
insulin-stimulated glucose uptake. In the past decade, a close relationship has been 
suggested between oxidative stress and insulin effects [36, 37]. In muscle cells, 
stimulation by oxidants such as hydrogen peroxide blocks insulin-induced glucose uptake 
and GLUT4 translocation by impairing upstream signaling [38, 39]. Oxidative stress has 
shown to increase IRS-1 degradation along with the activity of the ubiquitin-dependent 
proteolytic pathway in muscle cells. In addition, stress-mediated activation of serine 
kinases, with subsequent modulation of IRS-1 protein levels and functionality is 
associated with the effects of oxidative stress on insulin action. It has been shown that 
hydrogen peroxide induces the activity of various serine kinases, including p38 mitogen-
activated protein kinase, c-Jun N-terminal kinase, IKB kinase~, and ERK1/2, with 
subsequent phosphorylation of IRS-1 on Ser307 and selective degradation of IRS-1, 
ultimately leading to insulin resistance [40-43]. In fact, previous studies have reported 
elevated levels of oxidative products in the muscles of patients with type 2 diabetes [44, 
45] and diabetic mice [46]. In contrast, several antioxidants improve the insulin signaling 
of muscle cells for glucose uptake and reduce the production of oxidative products [38, 
47, 48], which supports a role for oxidative stress in the development of insulin 
resistance. 
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1-3. Fermented milk and milk casein hydrolysate 
Milk fermented with lactobacillus is recognized as a pleasant sour-tasting drink, 
which has superior storage properties, making it beneficial for human health. In recent 
years, through some studies [49-52], fermented milk has been shown to have useful 
functions including prolonged lifespan, antihypertensive, antitumorigenic effects, and 
immune system regulation. In addition, some types of fermented milk possess anti-
inflammatory and antioxidant properties [53-56]. 
Fermented milk is manufactured by fermenting skimmed milk with a starter culture. 
During this process, proteins contained in the milk casein are digested and converted 
into small peptides, which are absorbed more in amount from the intestines, compared 
to amino acids or large oligopeptides [57]. It has been suggested that fermented milk 
contains several particular peptides and amino acids that could influence multiple 
physiological effects. 
It has been shown that the fermentation of skim milk with a starter culture 
containing Lactobacillus helveticus (L. helveticus) has several beneficial effects including 
anti-inflammation and contains specific peptides, such as Val-Pro-Pro and lie-Pro-Pro. 
During the processing of these peptides, the importance of specific proteolytic enzymes 
in L. helveticus became apparent [58, 59]. However, L. helveticus-fermented milk still 
contains much unhydrolysed casein, and the productivity of peptides by milk 
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fermentation is limited. A new enzymatic method for manufacturing these peptides from 
casein was recently developed using an Aspergillus oryzae (A. oryzae) protease [60]. The 
peptide material produced by the A. oryzae protease has advantages over L. helveticus-
fermented milk in that the production cost is lower and the applications are more 
versatile. Milk casein hydrolysate (MCH) prepared from A. oryzae demonstrated 
significant antihypertensive effects in animals [60] and humans [61] as was observed 
with L. helveticus-fermented milk. Thus, MCH is a possibility even with same effects as 
well as L. helveticus-fermented milk. 
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1-4. The purpose of this study 
Muscle soreness, fatigue, and reduction of glucose metabolism that occurs with 
muscle damage are obstacles to the competitive ability and daily life after exercise. 
These features may lead to a decrease in performance and/or exercise motivation. 
Therefore, it is necessary to develop an approach to inhibit or reduce those events 
associated with muscle damage in both sports person and health enthusiasts. 
Previously, Aoi et al. showed that L. helveticus-fermented milk prevents muscle 
damage induced by acute exercise via activation of antioxidative enzymes of skeletal 
muscle in animals [62]. However, the effect of L. helveticus-fermented milk on muscle 
damage in human is unclear. Moreover, L. helveticus-fermented milk and MCH include 
common peptides [60, 63], suggesting the possibility that the same effects will be 
acquired. 
The purpose of this study was to clarify: (1) the effect of L. helveticus-fermented 
milk supplementation on glucose metabolism in damaged muscle after acute resistance 
exercise in young healthy men; (2) the effect of MCH supplementation on muscle 
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Chapter 2. The effect of fermented milk on muscle damage after 
exercise in young men 
2-1. Introduction 
Growing evidence has shown that impaired insulin sensitivity occurs physiologically 
with muscle damage, in contrast to the improvement in insulin sensitivity after non 
muscle-damaging exercise. Oxidative stress and certain inflammatory cytokines impair 
glucose uptake via inactivation of insulin signaling pathways in muscle cells [1-3]. 
Infiltration of phagocytes into the damaged muscle is observed after strenuous exercise, 
and an inflammatory response is implicated in the development of delayed-onset muscle 
damage [4, 5]. In addition, elevation of the levels of oxidative damage in cellular 
components is also observed in damaged muscle [4, 6]. Thus, inflammatory cytokines 
and oxidative stress can decrease insulin-dependent glucose uptake in exercise-induced 
damaged muscles [7]. Therefore, it was speculated that the decrease of glucose 
metabolism associated with muscle damage can be prevented by suppression of 
inflammation and oxidative stress. 
Fermented milk has several salutary effects, including anti-inflammatory and 
antioxidant effects [8-11]. Previously, it has been shown that L. helveticus-fermented 
milk prevents muscle damage induced by acute exercise via activation of antioxidative 
enzymes of skeletal muscle in an animal study [12], suggesting that fermented milk may 
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prevent the impairment of glucose metabolism associated with muscle damage. 
Additionally, in the previous study, the effect of long-term administration of L. helveticus-
fermented milk was observed [12], but the effect of a short-term administration, e.g. 
drinking in pre- and post-exercise, is not known. 
The purpose of this study was to investigate the effect of L. helveticus-fermented 
milk of short-term supplementation on glucose metabolism in damaged muscle after 




Eighteen healthy young men with no regular exercise regimen habits were recruited 
to participate in this study. The mean± S.E. characteristics of the participants were as 
follows: age, 21.6 ± 0.8 years; height, 171.1 ± 1.5 em; body weight, 59.9 ± 1.5 kg; body 
mass index (BMI}, 20.5 ± 0.4 kg/m 2; and body fat percentage, 16.2 ± 0.8%. All participants 
were free of the signs, symptoms, and history of any overt chronic disease. None of the 
participants had a history of smoking and none were currently taking any medications 
or dietary supplements. This study was approved by the Ethics Committee of Kyoto 
Prefectural University (2008, No. 22}, and all of the participants signed an informed 
consent form after reading about the design and protocol of the study. 
Study design 
All of the participants attended the three trials included in the study, rest with 
placebo intake (rest), exercise with placebo intake (placebo}, and exercise with 
fermented milk intake (fermented milk) in a repeated-measures experimental design. 
These trials were performed in a random order using a counter-balanced design and 
were separated by at least six weeks for any individual participants in order to avoid 
biasing of the muscle damage. The participants were also asked to refrain from caffeine 
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and alcohol ingestion 24 h before each trial and were asked not to eat or drink anything 
except for water from 22:00 on the night before the trial to the next morning. Dietary 
records on the day of the trial were performed to avoid significant differences of food 
intakes between rest, placebo, and fermented milk trials. In the first trial, an example of 
the recording method was shown to the participants beforehand, and they recorded 
dietary contents according to it. And, the recorded contents were repeated in the second 
and third trials. 
Examination beverage 
L. helveticus-fermented milk (Amiel S®, Calpis Co., Ltd., Kanagawa, Japan) was used 
in the fermented milk trial. A placebo beverage was unfermented milk, with adjusted 
contents of protein, fat, carbohydrate, and pH to be equivalent with that of fermented 
milk (Table 2-1). Each ofthe participants consumed 200 ml of each beverage once before 
and twice after exercise using a double-blinded method; therefore, they totally 
consumed 600 ml. 
Experiment schedule 
On the first experiment day of each trial, the participants came to laboratory at 9:00, 
where they sat on a chair until the beginning of the test. Subsequently, the test beverage 
25 
(placebo or L. helveticus-fermented milk) were consumed. In the rest trial, participants 
refrained from exertional activity, and were maintained in a state of rest. In the placebo 
and fermented milk trials, resistance exercise was performed from 30 min after 
consumption of the test beverage. Immediately after the exercise, the blood lactate was 
measured. Afterwards, the participants consumed the test beverage again at 1 h and 3 
h after the end of the exercise. The participants were asked to not to eat or drink 
anything except for water from 22:00 to the measurement of the next morning. 
On the second day of the study, the participants collected a sample from the first 
urine flow in the morning (urine accumulated overnight) and returned to the laboratory 
at 9:00. Subsequently, the body composition was measured and blood sample was 
collected from the antecubital vein. Glucose solution containing 75 g glucose (Trelan®-
G75, Ajinomoto Pharmaceuticals Co. Ltd., Tokyo, Japan) was orally consumed at 9:30, 
and the expiration gas was measured from 10:00 for 30 min in the supine position. Blood 
glucose was measured before, 30 min after, and 60 min after oral glucose administration, 
by a fingerstick prick. Next, the degree of subjective muscle soreness was evaluated. A 
schematic illustration of the experimental schedule was shown in Figure 2-1. 
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Table 2-1. Nutritional information of test beverage 
Placebo Fermented 
milk 
Energy (kcal) 102 102 
Protein (g) 6.6 6.6 
Val-Pro-Pro, lie-Pro-Pro (mg) 0.0 10.2 
Fat (g) 0.0 0.0 
Carbohydrate (g) 21.6 21.6 
pH 3.75 3.75 
Val ues are represented as composition included in 600 ml. 
Day 1 Day 2 
9:00 Arriva l at the laboratory 9:00 Arrival at the laboratory 
9:15 Consumption of test beverage 9:15 Measurement 




Oral glucose administration 
Exercise or rest 10:00 Expiration gas measurement 
10:30 10:30 Measurement 
Measurement Muscle soreness 
Blood parameters 
11:30 Consumption of test beverage 
(Fermented mi lk I placebo) 
13:30 Consumption of test beverage 
(Fermented mi lk I placebo) 
Figure 2-1. Schematic illustration of experimental schedule. 
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Exercise procedure 
After warm-up with a bicycle ergometer for 5 min and stretching, the participants 
performed resistance exercise for 45 min. The resistance exercise was composed of leg 
and bench presses using a compound-type resistance training machine (Senoh Ltd., 
Chiba, Japan). Five sets of leg and bench presses were performed at a strength of 70-
100% with a 12-repetition maximum (RM: maximum number of occurrence). This 
strength was determined using the methods of Drummond et al [13]. All participants 
performed 10 repetitions at the load of 100% 12 RM in 1-3 sets and then the load of 
70% 12 RM in 4-5 sets. The exercises were repeated at a pace of one repetition every 3 
sec, with a 2 min interval between sets. 
Indirect metabolic performance 
Oxygen consumption (V02) and carbon dioxide production (VC02) were measured 
using a breath-by-breath respiromonitor system (MetaMax 3B, Cortex, Leipzig, 
Germany). The respiratory quotient (RQ) and substrate utilization were calculated from 
the level of V02 and VC02, as described previously [14]. 
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Muscle soreness 
Subjective muscle soreness in the pectoralis major, quadriceps, and gluteus 
maximus muscles was evaluated by palpation and movement (bending and stretching) 
using the visual analogue scale (VAS). The participants were asked to indicate the 
intensity of perceived soreness for each muscle part on a 100-mm horizontal line. The 
left side stated "having no soreness", while the right side stated "having max soreness". 
The total soreness value was calculated by adding the soreness values for the 3 different 
muscles. 
Blood and urine parameters 
Blood samples were collected from the antecubital vein. The separated serum was 
stored at -80° until measurement. The blood lactate and glucose were measured using 
simple measuring instruments (blood lactate: Lactate Pro, Arkray, Inc., Kyoto, Japan; 
glucose: Glu Test, Sanwa Kagaku Kenkyusho Co., Ltd., Aichi, Japan). The analysis of 
triglyceride, cholesterols (LDL-cholesterol, HDL-cholesterol, and total cholesterol), free 
fatty acid, high sensitivity C-reactive protein (hs CRP), and creatine phosphokinase (CPK) 
in the serum was entrusted to FALCO Biosystems Ltd. (Kyoto, Japan). TN F-a and carbonyl 
protein levels in the serum were measured by using an enzyme-linked immunosorbent 
assay (ELISA) kit (TN F-a: Human TNF-alpha Quantikine ELISA Kit, R&D Systems, MN, USA; 
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carbonyl protein: Biocell™ Protein Carbonyl ELISA Assay, BioCell, Auckland, NZ). Oxygen 
radical absorbance capacity (ORAC), a marker that reports antioxidant capacity, was 
measured by using the methods of Watanabe et al [15]. The concentration of 8-hydroxy-
2'-deoxyguanosine (8-0HdG), a marker of DNA oxidative damage, was measured using 
an ELISA kit (ELISA kit for 8-0HdG, Japan Institute for the Control of Ageing, Shizuoka, 
Japan) on the gathered urine, and the total amount of 8-0HdG was calculated by the 
volume of urine. Moreover, measurement of the creatinine was requested (FALCO 
Biosystems Ltd.) and used to correct the amount of 8-0HdG. 
Statistical analysis 
All of the data were shown as the mean ±standard error. The repeated-measures 
analysis of variance (AN OVA) was used to compare the date the 3 trials. In the index of 
3 collection points per trial, such as blood glucose, 2-way repeated-measures ANOVA 
was used. If ANOVA indicated a significance difference, Tukey-Kramer test was used to 
determine the significance of the differences between mean values. Paired t-tests was 
used for data on blood lactate and muscle soreness with a normal distribution to 
compare between 2 trials. The significance level was assumed to be 5%. 
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2-3. Results 
Muscle damage parameters and blood lactate 
Immediately after exercise, the blood lactate value was markedly increased 
immediately after exercise, but it was significantly suppressed in the fermented milk trial, 
compared with placebo trial (placebo, 10.8 ± 0.9 mmoi/L vs. fermented milk, 8.6 ± 0.5 
mmoi/L, P = 0.04) (Figure 2-2). 
On the next day of the exercise, serum CPK was significantly elevated in the placebo 
and fermented milk trials compared with rest trial (rest, 96 ± 7 IU/L vs. placebo, 193 ± 27 
IU/L, P = 0.001; rest, 96 ± 7 IU/L vs. fermented milk, 152 ± 15 IU/L, P = 0.02}, although 
serum CPK of the fermented milk trial showed a tendency to decrease compared with 
placebo trial (placebo, 193 ± 27 IU/L vs. fermented milk, 152 ± 15 IU/L, P = 0.06} (Figure 
2-3). Muscle soreness of pectoralis major muscle was significantly suppressed by the 
consumption of fermented milk compared with that of placebo in the evaluation by 
palpation (P = 0.01} (Table 2-2). Muscle soreness of quadriceps and gluteus maximus 
muscles was no significant difference (quadriceps muscle: P = 0.48, gluteus maximus 
muscle: P = 0.50} (Table 2-2). The total score of muscle soreness in the three parts was 
significantly suppressed by the consumption of fermented milk compared with that of 
placebo (P = 0.02} (Table 2-2). In the evaluation by movements, the level of muscle 
soreness was also significantly suppressed (date not shown). 
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Figure 2-2. Comparison of blood lactate among placebo and fermented milk trials 
immediately after exercise. 
Values are represented as mean± S.E. for 18 participants. The trials analyzed include: 
Placebo, exercise with placebo intake; Fermented milk, exercise with fermented milk 
intake. Paired t-test. 
p = 0.02 
















Rest Placebo Fermented 
milk 
Figure 2-3. Comparison of serum CPK among rest, placebo, and fermented milk trials 
on the next day of exercise. 
Values are represented as mean ± S. E. for 18 participants. The trials analyzed include: 
Rest, rest with placebo intake; Placebo, exercise with placebo intake; Fermented milk, 
exercise with fermented milk intake. One-way ANOVA (Tukey-Kramer) . CPK, creatine 
phosphokinase. 
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Table 2-2. Comparison of muscle soreness among rest, placebo, and fermented milk trials on the next 
day of exercise 
Rest Placebo Fermented P-value 
milk 
Pectoralis major muscle (score) N.D. 5.2 ± 0.5 4.3 ± 0.5 0.01 
Quadriceps muscle (score) N.D. 3.3 ± 0.5 3.0 ± 0.5 0.48 
Gluteus maximus muscle (score) N.D. 5.6 ± 0.5 5.3 ± 0.5 0.50 
Total score (score) N.D. 14.2 ± 1.2 12.6 ± 1.1 0.02 
Values are represented as mean± S.E. for 18 participants. The trials analyzed include: Rest, rest with 
placebo intake; Placebo, exercise with placebo intake; Fermented milk, exercise with fermented milk 
intake. The total score was calculated by adding the soreness values for the 3 different muscles. 
Paired t-test. N.D., not detected. 
Indirect metabolic performance 
The RQ and carbohydrate oxidation were compared among the mean values of the 
three trials for 30 min after glucose administration on the next day of the exercise. The 
RQ was significantly decreased in the placebo trial compared with the rest trial (rest, 
0.88 ± 0.01 vs. placebo, 0.84 ± 0.02, P = 0.03), although this decrease was negated 
fermented milk trial (placebo, 0.84 ± 0.02 vs. fermented milk, 0.88 ± 0.01, P = 0.02) 
(Figure 2-4A). Carbohydrate oxidation was significantly decreased in the placebo trial 
compared with the rest trial (rest, 2.78 ± 0.02 mg/kg/min vs. placebo, 2.10 ± 0.31 
mg/kg/min, P = 0.02), although carbohydrate oxidation of the fermented milk trial 
showed a tendency to decrease compared with rest trial (rest, 2.78 ± 0.02 mg/kg/min 
vs. fermented milk, 2.41 ± 0.26 mg/kg/min, P = 0.08) (Figure 2-4B). On the other hand, 
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Figure 2-4. Comparison of respiratory metabolic performance among rest, placebo, 
and fermented milk trials on the next day of exercise. 
RQ (A) and carbohydrate oxidation (B) were calculated using oxygen consumption and 
carbon dioxide production and were compared among the mean values of the three 
trials for 30 min after glucose administration. Values are represented as mean ± S.E. 
for 18 participants. The trials analyzed include: Rest, rest with placebo intake; Placebo, 
exercise with placebo intake; Fermented milk, exercise with fermented milk intake. 
One-way ANOVA (Tukey-Kramer) . RQ, respiratory quotient. 
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Blood glucose and serum lipids 
On the next day of the exercise, blood glucose levels were increased after oral 
glucose administration, although the change was not deemed to be statistically 
significant among the three trials at fasting, 30 min, and 60 min (fasting: P = 0.34, 30 
min : P = 0.32, 60 min : P = 0.20} (Table 2-3). Levels of LDL-cholesterol, HDL-cholesterol, 
total cholesterol, triglyceride, and free fatty acids were not significantly changed among 
three trials (LDL-cholesterol: P = 0.19, HDL-cholesterol: P = 0.46, total cholesterol: P = 
0.35, triglyceride: P = 0.24, free fatty acids: P = 0.23} (Table 2-4). 
Table 2-3. Comparison of blood glucose level among rest, placebo, and fermented milk trials after 
oral glucose administration 
Rest Placebo Fermented P-value 
milk 
Fasting (mg/dL) 89 ± 2 87 ± 2 90 ± 2 0.34 
30 min (mg/dL) 148 ± 6 148 ± 6 157 ± 5 0.32 
60 min (mg/dL) 121 ± 6 122 ± 6 132 ± 7 0.20 
Values are represented as mean± S.E. for 18 participants. The trials analyzed include: Rest, rest with 
placebo intake; Placebo, exercise with placebo intake; Fermented milk, exercise with fermented milk 
intake. Two-way ANOVA. 
Table 2-4. Comparison of serum lipids among rest, placebo, and fermented milk trials on the next day 
of exercise 
Rest Placebo Fermented P-value 
milk 
LDL cholesterol (mg/dL) 84 ± 5 88 ± 5 91 ± 6 0.19 
HDL cholesterol (mg/dL) 57 ± 3 59 ± 3 59 ± 3 0.46 
Total cholesterol (mg/dL) 158 ± 7 163 ± 5 164 ± 7 0.35 
Triglycerides (mg/dL) 85 ± 12 80 ± 14 67 ± 7 0.24 
Free fatty acids (mEq/L) 0.38 ± 0.04 0.47 ± 0.06 0.38 ± 0.05 0.23 
Values are represented as mean± S.E. for 18 participants. The trials analyzed include: Rest, rest with 
placebo intake; Placebo, exercise with placebo intake; Fermented milk, exercise with fermented milk 
intake. One-way ANOVA. 
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Inflammation and oxidant stress parameters 
On the next day of the exercise, serum hs CRP was not significantly changed among 
the trials of the study, although it showed a tendency of increasing in the placebo trial, 
but not in the fermented milk trial (P = 0.32} (Table 2-5}. Serum TNF-a and carbonyl 
protein levels were not significant changed among the trials of the study, nor were urine 
8-0HdG levels (serum TN F-a: P = 0.13, serum carbonyl protein: P = 0.06, urine 8-0HdG: 
P = 0.71} (Table 2-5}. However, the exercise trial reported significantly decreased levels 
of serum ORAC compared with the rest trial (rest, 6.9 ± 0.41lmol trolox equivalent (TE}/g 
vs. placebo, 6.0 ± 0.3 11mol TE/g, P = 0.01}, although this decrease was not observed in 
the fermented milk trial (rest, 6.9 ± 0.41lmol TE vs. fermented milk, 6.2 ± 0.3 11mol TE/g, 
P = 0.16} (Figure 2-5}. 
Table 2-5. Comparison of inflammatory factors and oxidant stress marker among rest, placebo, and 
fermented milk trials on the next day of exercise 
Rest Placebo Fermented P-value 
milk 
Serum hs CRP (ng/mL) 89 ± 12 114 ± 22 79 ± 11 0.32 
Serum TN F-a (pg/mL) 0.161 ± 0.002 0.166 ± 0.001 0.170 ± 0.004 0.13 
Serum carbonyl protein (nmol/mg) 0.086 ± 0.003 0.089 ± 0.004 0.096 ± 0.003 0.06 
Urine 8-0HdG (IJ.g) 1.82 ± 0.16 1.70 ± 0.16 1.72 ± 0.19 0.71 
Values are represented as mean ± S.E . for 12 participants (hs CRP and TNF-a), 18 participants 
(carbonyl protein), and 13 participants (8-0HdG). The trials analyzed include: Rest, rest with placebo 
intake; Placebo, exercise with placebo intake; Fermented milk, exercise with fermented milk intake. 
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Figure 2-5. Comparison of serum ORAC among rest, placebo, and fermented milk trials 
on the next day of exercise. 
Values are represented as mean ± S. E. for 18 participants. The trials analyzed include: 
Rest, rest with placebo intake; Placebo, exercise with placebo intake; Fermented milk, 
exercise with fermented milk intake. One-way ANOVA (Tukey-Kramer). ORAC, oxygen 
radical absorbance capacity; TE, trolox equivalent. 
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2-4. Discussion 
The present study revealed the following main findings: (1) parameters of muscle 
damage were elevated on the next day after acute resistance exercise; (2) the decrease 
of carbohydrate oxidation along with RQ was observed with exercise; and (3) the muscle 
soreness and metabolic changes were mitigated by the consumption of L. helveticus-
fermented milk in pre- and post-exercise. Previously, it had been unclear whether dietary 
intervention can improve metabolic impairment after muscle-damaging exercise. 
Collectively, these observations demonstrate that dietary fermented milk improved the 
impairment of glucose metabolism associated with exercise-induced muscle damage in 
humans. Moreover, this study showed that even the supplementation of L. helveticus-
fermented milk on the day of exercise suppressed muscle damage, although in a 
previous study [12], L. helveticus-fermented milk prevented muscle damage by 3 weeks 
of continuous ingestion. Therefore, this study for the first time identified the effect of a 
shot-term administration of the L. helveticus-fermented milk in humans. 
In recent years, certain methods of reducing muscle damage following exercise 
have been studied, such as the ingestion of milk. Cockburn et al. [16] suggested that 
consumption of unfermented milk attenuates the decreases in isokinetic muscle 
performance and the increases in CK following muscle damaging exercise. Furthermore, 
consumption of milk immediately after muscle-damaging exercise may limit the 
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decreases in one-off sprinting performance and likely reduces the increases in agility 
time and the ability to perform repeated sprints during physiological simulation of field-
based team sports [17]. A possible mechanism for milk-inhibited muscle damage is the 
ingestion of proteins and carbohydrates. Therefore, in this study, the placebo trial that 
used unfermented milk may have also suppressed muscle damage to some extent. 
However, these results showed that fermented milk is more effective than unfermented 
milk in parameters such as muscle damage and glucose metabolism. 
Generally, it is well-known that a single bout of exercise elevates glucose uptake for 
a period of time post-exercise [18-20]. However, this study have shown that insulin-
mediated glucose uptake in muscle is decreased by muscle-damaging exercises, but not 
by non-muscle-damaging exercises [21]. Therefore, the decreases of carbohydrate 
oxidation and RQ in the present study are suspected to be caused by insulin-dependent 
glucose uptake in damaged muscle. This decrease of glucose uptake is presumably due 
to a reduction of GLUT4 translocation via the insulin signaling pathway, which is the rate-
limiting step in glucose metabolism. It has been reported that some inflammatory 
cytokines and chemokines, such as TNF-a and IL-1, attenuate the activity of insulin-
mediated signaling in muscle cells [22, 23].1n addition, oxidative stress can also decrease 
glucose uptake by reducing the activity of insulin-mediated signaling [3, 24, 25]. In the 
damaged muscle on the next day of exercise, these cytokines and oxidative components 
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are elevated [26-28], which could lead to the impairment of insulin-dependent glucose 
uptake. However, because it did not find any significant changes of inflammatory 
markers and oxidative products in serum and urine, the response is considered to be 
limited to muscle tissue, rather than the whole body, as suggested in the preceding study 
[21]. 
Previously, Aoi et al. demonstrated that L. helveticus-fermented milk attenuates 
delayed-onset muscle damage after acute exercise in rats [12]. In this study, phagocyte 
infiltration and inflammatory cytokines expression, markers of inflammation in damaged 
muscle, were markedly reduced by the consumption of fermented milk. In addition, lipid 
peroxide levels were elevated after exercise, although the fermented milk uptake 
significantly reduced this elevation. Therefore, these observations suggest that 
fermented milk consumption mitigated inflammation and oxidative stress as well as 
muscle damage, which results in improvements in glucose metabolism by maintaining 
the insulin signaling pathway. In fact, the present study showed that ORAC, a marker of 
antioxidant capacity, was reduced in the placebo trial, but not in the fermented milk trial. 
Thus, the inhibitory effect of glucose metabolic impairment and muscle damage may be 
associated with elevated antioxidant levels caused by the consumption of fermented 
milk. Additionally, Aoi et al. demonstrated that, in the skeletal muscle of rats, fermented 
milk upregulates expression of antioxidant enzymes, such as superoxide dismutase-2, 
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catalase, and glutathione S-transferase a-1 [12]. In addition, heat shock protein 70, a 
chaperone protein that can function as an antioxidant and an anti-inflammatory agent, 
was also elevated by the consumption of fermented milk. These observations suggest 
that fermented milk improves glucose metabolism and muscle damage at least, in part, 
by controlling endogenous antioxidant and anti-inflammation factors, a hypothesis that 
is supported by the ORAC results in the present study. 
Although the detailed mechanisms of the effects of fermented milk on mitigating 
muscle damage remain unclear, small peptides present in fermented milk may be the 
causable agent, because fermented milk is more effective than unfermented milk. L. 
helveticus-fermented milk is manufactured by fermenting skim milk with a starter 
culture containing L. helveticus. During this process, the proteins in skim milk are 
digested by Lactobacillus and converted into small peptides, which are absorbed more 
in amount from the intestines compared to amino acids or large oligopeptides. Such 
peptides may also have additional physiological benefits aside from their use as a source 
of protein. Several studies have reported that peptides from fermented milk have 
various salutary effects [29]. The present study suggests that small digested peptides in 
fermented milk may contribute to increasing the level of antioxidant capacity in muscle. 
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2-5. Conclusion 
L. helveticus-fermented milk supplementation improved glucose metabolism and 
alleviated the effects of muscle soreness after high-intensity exercise in young men, 
possibly associated with the regulation of antioxidant capacity. Moreover, the present 
study demonstrated the beneficial effect by a short-term supplementation before and 
after exercise. L. helveticus-fermented milk is expected to contribute to the maintenance 
of an athlete's performance. 
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Chapter 3. The effect of milk casein hydrolysate on muscle 
damage after exercise in middle-aged to elderly men 
3-1. Introduction 
Physical inactivity is the fourth leading cause of death worldwide in life style [1], 
which corresponds to the "pandemic" state. In contrast, daily exercise prevents and 
improves metabolic syndrome, a pre-disease state; thus, it leads to the prevention of 
non-communicable diseases [2, 3]. Based on the background, the World Health 
Organization {WHO) announced global recommendation on physical activity for health, 
particularly for middle-aged to elderly {over 40 years) people [4, 5] who is higher the risk 
of metabolic diseases than younger people [6]. Walking is one of the major exercises 
recommended for middle-aged to elderly people, because it can be performed easily 
and safely. It has actually been reported that habitual walking prevented or improved 
cardiovascular diseases and overweight [7-9]. However, middle-aged to elderly people 
are more susceptible to muscle soreness and fatigue than young people [10, 11]; which 
could cause a decrease in their motivation for exercise. 
In Chapter 2, it was determined that L. helveticus-fermented milk supplementation 
improved glucose metabolism and alleviated the effects of muscle soreness after high-
intensity exercise in young healthy men. The active ingredient in L. helveticus-fermented 
milk was considered to be peptides produced by fermentation. These peptides can be 
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released via fermentation by L. helveticus or via enzymatic hydrolysis by A. oryzae 
protease [12] from casein, a major protein in milk. In fact, in our unpublished study, it 
has been found, as well as L. helveticus-fermented milk, that MCH produced by the A. 
oryzae protease improved muscle damage after high-intensity exercise in young men. 
However, the effect on populations other than young people, particularly middle-aged 
and elderly people is not clear. Moreover, the effect on regular common exercise, such 
as "walking exercise", is also obscure. 
The purpose of this study was to investigate the effect of short-term 
supplementation of MCH on muscle soreness and fatigue in damaged muscle after acute 




Fourteen healthy middle-aged to elderly men with no regular exercise regimen 
habits were recruited to participate in this study. The mean± S.E. characteristics of the 
participants were as follows: age, 56.6 ± 2.8 years; height, 168.9 ± 1.4 em; body weight, 
68.4 ± 1.9 kg; BMI, 23.9 ± 0.5 kg/m 2; and body fat percentage, 22.6 ± 1.1%. All 
participants were free of the signs, symptoms, and history of any overt chronic diseases. 
None of the participants were currently taking any medications or dietary supplements. 
This study was approved by the Ethics Committee of Kyoto Prefectural University (2013, 
No. 45), and all of the participants signed an informed consent form after reading about 
the design and protocol of the study. 
Study design 
All of the participants attended the two trials included in the study, exercise with 
placebo intake (placebo) and exercise with MCH intake (MCH) in a repeated-measures 
experimental design. These trials were performed in a random order using a counter-
balanced design and were separated by at least two weeks for any individual participants 
in order to avoid biasing of the muscle damage. The participants were also asked to 
refrain from caffeine and alcohol ingestion 24 h before each trial and were asked not to 
so 
eat or drink anything except for water from 22:00 on the night before the trial to the 
next morning. Dietary records on the day of the trial were performed to avoid significant 
differences of food intakes between placebo and MCH trials. In the first trial, an example 
of the recording method was shown to the participants beforehand, and they recorded 
dietary contents according to it. And, the recorded contents were repeated in the second 
trial. 
Examination tablets 
The MCH hydrolyzed casein was produced by proteolytic enzymes. MCH containing 
peptides were prepared according to a previously described procedure [12]. The 
powdered casein hydrolysate was punch-pressed into tablets after the addition of 
diluents, emulsifier, and lubricant {test sample). The amount of peptides in the test 
sample was measured by the liquid chromatography-mass spectrometry method as 
described in the previous report [13] with some modification. Val-Pro-Pro and lie-Pro-
Pro were quantified using the internal standard method with Val-Pro-Pro isotope {{13C5} 
Vai-{ 13C5} Pro-Pro, m/z 324.2} and lie-Pro-Pro isotope {lle-{13C5} Pro-Pro, m/z 332.2} 
obtained from SCRUM Inc. {Tokyo, Japan). The placebo employed was non-hydrolyzed 
casein, and it was also presented in the shape of a tablet {Table 3-1}. Each of the 
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participants consumed 2 tablets with a cup of water before and after the exercise, using 
a double-blinded method. 
Experiment schedule 
On the first experiment day of each trial, the participants ate breakfast at 7:30 and 
came to laboratory at 9:00, where they sat on a chair until the beginning of the test. 
Subsequently, the test tablets (placebo or MCH) were consumed. Walking exercise was 
performed from 30 min after consumption of the test tablets. During the exercise, the 
heart rate and the rating of perceived exertion (RPE)-the Borg 15 points (6-20) scale, 
were measured. Immediately after the exercise, the blood lactate, blood glucose, and 
fatigue grade were measured. Afterwards, the participants consumed the test tablets 
again at 30 min after the end of the exercise. The participants were asked to not to eat 
or drink anything except for water from 22:00 to the measurement of the next morning. 
On the second day of the study, the participants ate breakfast (steamed rice, 200 g) 
at 7:30 and returned to the laboratory at 9:00. Subsequently, the body composition was 
measured and blood sample was collected from capillary using a fingerstick test method. 
Then, blood pressure, heart rate, skin blood flow, and pulse wave velocity (PWV) were 
measured. Next, the degree of subjective muscle soreness was evaluated. A schematic 








Table 3-1. Nutritional information of test tablet 
Placebo MCH 
Energy (kcal) 5.4 5.4 
Protein (g) 0.4 0.3 
Free amino acid (mg) 0.0 182 
Peptide (mg) 0.0 154 
Val-Pro-Pro (mg) 0.0 1.4 
lie-Pro-Pro (mg) 0.0 2.0 
Fat (g) 0.04 0.04 
Carbohydrate (g) 0.9 0.9 
Sodium (mg) 5.0 5.0 
Values are represented as composition included in 
4 tablets. 
Day 1 
Intake of breakfast 
Arriva l at the laboratory 
Consumption of test tablets 





Consumption of test tablets 
(MCH I placebo) 
Day 2 
7:30 Intake of breakfa st 






Figure 3-1. Schematic illustration of experimental schedule. 
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Exercise procedure 
After stretching, the participants performed walking exercise for 30 min. The 
walking exercise was performed on a downhill treadmill (My Mountain 5050, Tobeone 
Co., Ltd., Gyeonggi-do, Republic of Korea) at a 5% decline grade. Walking speed was 
increased to 5 km/h after a warming-up period at 3 km/h for 2 min, and it was 
maintained at that speed until the end of exercise. Heart rate and RPE were measured 
every 3 min during the exercise. 
Fatigue grade 
Two questionnaires using a VAS and a profile of mood state (POMS) were used to 
evaluate the fatigue grade immediately after the exercise. Using the VAS, the 
participants were asked to indicate the intensity of perceived fatigue on a 100-mm 
horizontal line. The left side stated "having no fatigue", while the right side stated 
"having max fatigue". The POMS questionnaire consists of 65 items, providing answers 
ranging from 0 (not at all) to 4 (extremely). That can be consolidated into six mood scales: 




Subjective muscle soreness in the femoral, crural, and gluteus maximus muscles 
was evaluated by palpation and movement (bending and stretching) using the VAS. The 
participants were asked to indicate the intensity of perceived soreness for each muscle 
part on a 100-mm horizontal line. The left side stated "having no soreness", while the 
right side stated "having max soreness". The total soreness value was calculated by 
adding the soreness values for the 3 different muscles. 
Blood parameters 
Blood samples were collected from capillary using a fingerstick test method. The 
separated plasma was stored at -80° until measurement. The blood lactate and glucose 
were measured using simple measuring instruments (blood lactate: Lactate Pro, Arkray, 
Inc., Kyoto, Japan; glucose: Glu Test, Sanwa Kagaku Kenkyusho Co., Ltd., Aichi, Japan). CK 
and the insulin level in the plasma were measured by using an ELISA kit (CK: 
MaxDiscovery™ Creatin kinase Enzymatic Assay kit, Bioo Scientific Co., TX, USA; insulin: 
Mercodia Ultrasensitive Human Insulin ELISA, MercodiaAB, Uppsala, Sweden). 
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Cardiovascular-related parameters 
The blood pressure and heart rate were monitored with a humerus 
sphygmomanometer (EW3100, Panasonic Electric Works Co., Ltd., Osaka, Japan). The 
skin blood flow was measured with a laser doppler blood perfusion imager (PeriScan 
PIM 3 System, Integral Co., Tokyo, Japan). The PWV was calculated using a blood-
pressure pulse wave inspection apparatus (FORM BP-203PRE, Omron Colin Co., Ltd., 
Tokyo, Japan) in the supine decubitus position. 
Statistical analysis 
All of the data were shown as the mean ± standard error. Wilcoxon signed-ranks 
test was used for data on blood lactate, plasma insulin, and muscle soreness with a non-
normal distribution. Paired t-test was used for data on other parameters with a normal 
distribution. The significance level was assumed to be 5%. 
56 
3-3. Results 
Heart rate and RPE 
Heart rate gradually increased over time during the exercise, and reached 87.1 ± 
2.5 beats/min (placebo) and 86.4 ± 2.9 beats/min (MCH) at the end ofthe exercise, when 
RPE showed scores of 11.5 ± 0.7 (placebo) and 11.4 ± 0.5 (MCH). No significant 
differences were found between the placebo and MCH trials in either the heart rate (P = 
0.32) or the RPE (P = 0.45) throughout the exercise, indicating that the same exercise 
load was applied to both conditions. 
Fatigue grade 
In the examination using VAS, the fatigue grade immediately after exercise showed 
a significantly low value for the MCH trial, compared with the placebo trial (placebo, 3.4 
± 0.5 score vs. MCH, 2.5 ± 0.4 score, P = 0.03) (Figure 3-2A). Moreover, in the examination 
using POMS, the score of the fatigue-related item immediately after exercise was also 
significantly lower for the MCH trial, compared with the placebo trial (placebo, 6.3 ± 1.1 
score vs. MCH, 5.0 ± 1.0 score, P = 0.04) (Figure 3-2B). None of the other items in the 
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Figure 3-2. Comparison of fatigue grade among placebo and MCH trials immediately 
after exercise. 
VAS (A) and POMS (B) were used to evaluate the fatigue grade immediately after the 
exercise. Values are represented as mean± S.E. for 14 participants. The trials analyzed 
included : Placebo, exercise with placebo intake; MCH, exercise with MCH intake. 
Paired t-test. VAS, visual analog scale; POMS, profile of mood state. 
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Muscle soreness 
On the next day of exercise, using the evaluation by palpation, the level of muscle 
soreness in the femoral and crural muscles was significantly suppressed in the MCH trial, 
compared with the placebo trial (femoral muscle : P = 0.02, crural muscle: P = 0.04) (Table 
3-2). The significant effect was not found in the gluteus maximus muscle (P = 0.24) (Table 
3-2). The total score for muscle soreness in the three muscles was significantly 
suppressed in the MCH trial, compared with the placebo trial (P = 0.03) (Table 3-2). In 
the evaluation by movements, the level of muscle soreness also showed a tendency to 
be suppressed in the MCH trial (date not shown). Significant difference in the level of 
muscle soreness was not observed between first and second trials, showing no repeat-
bout effects. 
Table 3-2. Comparison of muscle soreness among placebo and MCH trials on the next 
day of exercise 
Placebo MCH P- value 
Femoral muscle (score) 1.8 ± 0.6 1.1 ± 0.4 0.02 
Crural muscle (score) 1.7 ± 0.6 1.4 ± 0.6 0.04 
Gluteus maximus muscle (score) 1.2 ± 0.5 0.9 ± 0.3 0.24 
Total score (score) 4.7 ± 1.5 3.4 ± 1.3 0.03 
Values are represented as mean± S.E. for 14 participants. The trials analyzed included: 
Placebo, exercise with placebo intake; MCH, exercise with MCH intake. The total score 




Immediately after the exercise, the blood lactate values showed a tendency for 
lower values in the MCH trial, compared with the placebo trial (P = 0.08) (Table 3-3). The 
blood glucose levels obtained immediately after exercise did not show any significant 
difference between the placebo and MCH trials (P = 0.34) (Table 3-3). 
On the next day of exercise, no significant differences were found between the 
placebo and MCH trials for the blood glucose, plasma CK, or plasma insulin (blood 
glucose: P = 0.29, plasma CK: P = 0.36, plasma insulin: P = 0.83) (Table 3-3). 
Table 3-3. Comparison of blood parameters among placebo and MCH trials after 
exercise 
Placebo MCH P- value 
Immediately after exercise 
Blood lactate (mmoi/L) 1.6 ± 0.2 1.2 ± 0.1 0.08 
Blood glucose (mg/dL) 88 ± 4 90 ± 3 0.34 
The next day of exercise 
Blood glucose (mg/dL) 131 ± 9 127 ± 7 0.29 
Plasma CK (I U/L) 147 ± 16 153 ± 8 0.36 
Plasma insulin (1-lU/mL) 16 ± 3 20 ± 5 0.83 
Values are represented as mean ± S.E. for 14 participants. The trials analyzed 
included : Placebo, exercise with placebo intake; MCH, exercise with MCH intake. 
Blood lactate and plasma insulin : Wilcoxon signed-ranks test, other parameters: 
Paired t-test. CK, creatine kinase. 
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Cardiovascular-related parameters 
On the next day of exercise, no significant difference were shown in the systolic 
blood pressure and diastolic blood pressure between the placebo and MCH trials 
(systolic blood pressure: P = 0.68, diastolic blood pressure: P = 0.18} (Table 3-4). The 
heart rate showed a tendency for lower value in the MCH trial, compared with placebo 
trial (P = 0.08} (Table 3-4). No significant changes were shown in the skin blood flow or 
PWV between the placebo and MCH trials (skin blood flow: P = 0.44, PWV: P = 0.32) 
(Table 3-4). 
Table 3-4. Comparison of cardiovascular-related parameters among placebo and MCH 
trials on the next day of exercise 
Placebo MCH P- value 
Systolic blood pressure (mmHg) 116 ± 4 115 ± 4 0.68 
Diastolic blood pressure (mmHg) 80 ± 3 78 ± 2 0.18 
Heart rate (beats/min) 69 ± 2 67 ± 2 0.08 
Blood skin flow (PU) 106 ± 6 106 ± 6 0.44 
PWV (cm/s) 1373 ± 53 1358 ± 56 0.32 
Values are represented as mean ± S.E. for 14 participants. The trials analyzed included : 
Placebo, exercise with placebo intake; MCH, exercise with MCH intake. Paired t -test. PWV, 
pulse wave velocity. 
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3-4. Discussion 
The present study revealed that the muscle soreness and fatigue parameters 
observed after downhill walking exercise, although these parameters were mitigated by 
the intake of MCH, with pre- and post-exercise. These observations primarily 
demonstrate that the effect of diet supplementation using milk-related peptides in 
middle-aged to elderly men. These results would help greatly to the improvement of the 
exercise habits of middle-aged to elderly men. Daily exercise is effective in the 
prevention and improvement of non-communicable diseases. Based on the research 
findings published by the WHO and Lee et al. [14], more than 150 min a week of 
moderate exercise, equivalent to brisk walking, is enough to ensure that one does not 
fall into the "physical inactivity" category, which accounts for 35.2% of the population 
worldwide. According to the statistics published by the WHO, physical inactivity is a 
major cause of death and development of non-communicable diseases, and it 
corresponds to 9.4% of total death risk. Accordingly, the WHO recommends that adults 
aged 18-64 years should do at least 150 min of moderate-intensity aerobic physical 
activity each week and increase that amount to 300 min if possible [5]. However, the half 
of participants drops out exercise within 6 months from the beginning, as shown in 
Dishman's report [15]. In contrast to barriers for younger adults, the major barrier for 
the elderly is related to health-related concerns [16], and it is difficult for over 80% of 
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elderly people to participate in exercise due to at least one physical or psychological 
barrier [17].1n addition, in an investigation of community-dwelling elderly people, health 
problems and pain were also suggested as the most common barrier to exercise [18]. 
Muscle soreness also continues after the next day of exercise, and this may interfere 
with activities in daily life. Moreover, muscle soreness after exercise could be one of the 
factors preventing the habituation of exercise [19]. In this study, MCH suppressed muscle 
soreness and fatigue in middle-aged to elderly men, which may contribute to the 
habituation of exercise. 
In the present study, the subjective fatigue grade immediately after downhill 
walking exercise showed lower values in the MCH intake group. Although fatigue induced 
by exercise is caused by various peripheral and psychological factors [20], intracellular 
acidosis could be a key role for muscle fatigue. Even minimal decrease in muscle pH 
interferes with cross-bridge binding and ATPase activity due to competitive binding and 
reduced enzyme function [21]. Decreased intracellular pH may also impair oxidative 
enzyme activity and may adversely affect ryanodine receptor function [22]. Lactic acid, 
a major source of protons, is rapidly produced by muscle contraction, lowering the pH 
and inhibiting muscle contraction. Furthermore, the blood lactate after exercise tended 
to show lower values by ingesting MCH. Thus, these observations suggest that the MCH 
intake suppressed the subjective fatigue grade after exercise, which could be mediated 
63 
by improving muscular acidosis. Although detail mechanism is unclear, a possibility 
might be caused by improvement of peripheral blood flow after intake of MCH. In the 
previous animal study [23], milk-derived peptides increased concentrations of plasma 
nitrate and nitrite, which expands a diameter of an artery and increases a blood flow 
after oral administration. Therefore, MCH might elevate oxygen supply to muscle cells 
during exercise and induce a predominance of aerobic metabolism over anaerobic 
metabolism, which leads to the prevention of acidosis via suppression of lactic acid 
production. 
It is well known that muscle soreness generally occurs as a part of delayed-onset 
muscle damage [24]. Therefore, MCH might reduce the degree of muscle soreness by 
suppressing the muscle damage. Delayed-onset muscle damage is caused by a variety of 
factors, but it is considered that oxidative stress and inflammatory cytokines are involved, 
at least to some extent. Indeed, oxidative stress and inflammatory cytokines also 
increase at the initiation and developmental stages of muscle damage [25, 26]. Therefore, 
it may be considered that muscle soreness will also be reduced by suppressing oxidative 
stress and inflammatory cytokines. MCH contains specific peptides, such as Val-Pro-Pro 
and lie-Pro-Pro, which are equivalent to L. helveticus-fermented milk. As shown in the 
previous study [27] and Chapter 2, L. helveticus-fermented milk was found to inhibit the 
muscle damage by adjusting the antioxidant capacity. Therefore, these previous studies 
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support this study's concept that the consumption of MCH reduced muscle damage 
through regulating the antioxidant capacity induced by casein-derived peptides, which 
might also contribute the suppression of muscle soreness and fatigue induced by muscle 
damage. In the present study, CK, a muscle damage marker, was not changed between 
conditions, which might be caused by characteristics of subjects such as lower 
inflammatory response in middle-aged and elderly people than young people [28]. It has 
been documented that a decrease in muscle content in type II fibers linked with aging 
[29] and type II fibers are more susceptible to muscle damage than type I fibers [30]. 
Lower levels of muscle damage response in the middle-aged and elderly people may be 
explained by their lower muscle content of type II fibers. 
The previous study [31] showed that MCH containing antihypertensive peptides 
such as Val-Pro-Pro and lie-Pro-Pro were able to improve human blood pressure and 
PWV by continuous ingestion. However, the cardiovascular parameter was not changed 
by ingestion MCH in the present study, which might be affected by duration and amount 
of intake. These peptides increased concentrations of plasma nitrate and nitrite, which 
expands a diameter of an artery and increase a blood flow after a single oral 
administration to Wistar rats [23]. Therefore, this may occur in the present study during 
walking exercise, and affect a tendency for heart rate, although nitric oxide was not 
measured at that time. 
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The detailed mechanisms of the effects of MCH on mitigating muscle soreness and 
fatigue remain unclear. As discussed in Chapter 2, small peptides present in MCH as well 
as L. helveticus-fermented milk may be the causative agents. In addition to such peptides, 
amino acids are another possible ingredient contained in MCH that may be involved in 
the effect shown by the consumption of MCH, since the amount of amino acids in MCH 
is larger, compared with the placebo tablets. Moreover, despite having only a very small 
amount of peptides and amino acids, MCH exerted an inhibitory effect on muscle 
soreness and fatigue. In a previous study [32], the peptides from a milk beverage were 
absorbed intact into the circulation, which suggests that the peptides might have a direct 
function in peripheral tissues. Therefore, it is necessary to examine the direct effect of 
amino acids and peptides on skeletal muscle after absorption. 
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3-5. Conclusion 
MCH supplementation alleviated muscle soreness and fatigue induced by downhill 
walking in middle-aged to elderly men. Moreover, the beneficial effect has been 
obtained by a short-term supplementation of MCH before and after exercise. MCH may 
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Chapter 4. General discussion and conclusions 
This study investigated the short-term effect of L. helveticus-fermented milk and 
MCH supplementation on muscle damage after exercise in humans. In the previous study 
[1], L. helveticus-fermented milk prevented muscle damage by continuous ingestion in 
rats. Moreover, in our unpublished recent study using mice, MCH alleviated muscle 
damage through a short-term administration. 
In Chapter 2, it was determined that fermented milk supplementation improved 
glucose metabolism and alleviated the effects of muscle soreness after high-intensity 
exercise in young men, possibly associated with the regulation of antioxidant capacity. 
In this study, the effect was observed in the commercial L. helveticus-fermented milk 
(Amiel S®) but not in the extracted component or synthesized sample. Moreover, this 
study demonstrated an effect by a short-term supplementation of L. helveticus-
fermented milk before and after exercise. Therefore, L. helveticus-fermented milk is 
considered to have a high utility value in daily exercise. 
In the sports field, muscle damage and muscle fatigue caused by routine training 
and games are known to lead to performance degradation. In particular, muscle damage 
is caused by high-intensity training just before a game, when a decrease in energy 
production, endurance, and muscle strength occurs. Thus, it is believed that a maximum 
capacity cannot be exerted in a game. Therefore, considering the decline in performance 
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caused by muscle damage and the combination of exercise and a nutritionally balanced 
diet, it is necessary to improve physical performance and competitive ability. In this study, 
L. helveticus-fermented milk suppressed muscle damage and improved glucose 
metabolism, therefore, L. helveticus-fermented milk is expected to contribute to the 
maintenance of an athlete's performance. 
In Chapter 3, it was demonstrated that MCH supplementation alleviated muscle 
soreness and fatigue induced by downhill walking in middle-aged to elderly men. In this 
study, as the exercise protocol mimicked movement in daily life, the "walking exercise" 
was performed, and an inhibitory effect on muscle soreness and fatigue was observed. 
Thus, MCH may be useful for persons who perform physical activity for health promotion. 
The powder containing MCH, for example, could be used by manufacture in capsule or 
tablet form. Moreover, MCH could be utilized by addition to a beverage, yogurt, jelly, or 
similar consumables. Since the described adaptations are possible, MCH could be 
effectively used in sports drinks, general foods, and dietary supplements. Therefore, 
since MCH was effective even with a short-term supplementation in daily exercise for 
health promotion, the utility value is likely to be very high. 
The active ingredient of L. helveticus-fermented milk and MCH on mitigating muscle 
damage remain unclear. As discussed in Chapter 2 and 3, small peptides present in L. 
helveticus-fermented milk and MCH may be the causative agents. Moreover, despite 
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having only a very small amount of peptides and amino acids, L. helveticus-fermented 
milk and MCH exerted an inhibitory effect on muscle damage. In the previous study [2], 
the peptides from a milk beverage were absorbed intact into the circulation, which 
suggests that the peptides might have a direct function in peripheral tissues. In addition, 
growing evidence has been shown that the supplementation of lactic acid bacteria can 
affect the immune system through improving the intestinal environment, such as the 
intestinal flora, immunocompetent cells, and lactic acid bacteria [3]. Therefore, it is 
necessary to examine not only the direct effect of amino acids and peptides on skeletal 
muscle after absorption, but also any indirect effects, such as the regulation of the 
intestinal bacteria and brain-gut interaction. 
Another limitation of this study is that the mechanism of muscle damage of L. 
helveticus-fermented milk and MCH is not elucidated. Similar to the previous study [1], 
this study suggests that antioxidant capacity obtained by their intake is associated with 
the improvement muscle damage. However, the response is considered to be limited to 
muscle tissue, rather than the whole body, as suggested in a previous study [4]. 
Further research is required to examine the detailed mechanisms of the effect of 
fermented milk and MCH in mitigating muscle damage, along with the benefit of 
fermented milk and MCH in different subjects and conditions. 
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